RemedyRepack Inc. recalls Glipizide 2.5 mg ER Tablets, Manufactured by Watson Laboratories, Inc., Parsippany, NJ 07054, Repackaged by RemedyRepac…
- Recall date
- February 7, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0482-2017
- FDA classification
- Class II
- Brand / firm
- RemedyRepack Inc.
- Sold / distributed
- Product was distributed to a sold customer in FL.
Why it was recalled
Failed Dissolution Specifications
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Glipizide 2.5 mg ER Tablets, Manufactured by Watson Laboratories, Inc., Parsippany, NJ 07054, Repackaged by RemedyRepack, Indiana, PA 15701, NDC 52125-0764-02
Get recall alerts
Free email alert whenever RemedyRepack Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: RemedyRepack Inc.